(Q28277452)

1

0 references

Eyal Sagiv

2

0 references

Eliezer Liberman

3

0 references

Diana Kazanov

4

0 references

Nadir Arber

Identification of apoptotic cells by formamide-induced dna denaturation in condensed chromatin

5

0 references

language of work or name

English

0 references

publication date

15 January 2007

0 references

published in

Cancer

0 references

volume

109

0 references

issue

2

0 references

page(s)

188-97

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

Analysis of the beta-catenin/T cell factor signaling pathway in 36 gastrointestinal and liver cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

E-cadherin/catenin/cytoskeleton complex: a regulator of cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Tyrosine phosphorylation and cadherin/catenin function

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Altered cell adhesion activity by pervanadate due to the dissociation of alpha-catenin from the E-cadherin.catenin complex

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Identification of c-MYC as a target of the APC pathway

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Frequent beta-catenin aberration in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

PUMA induces the rapid apoptosis of colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

PUMA, a novel proapoptotic gene, is induced by p53

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Mitochondria and apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Protein kinase G activates the JNK1 pathway via phosphorylation of MEKK1.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Dysregulation of beta-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Analysis of beta-catenin gene mutations in pancreatic tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Loss of beta-catenin expression in metastatic gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Targeting the active beta-catenin pathway to treat cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Adenoviral vectors for gene transfer and therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

The suppression of colon cancer cell growth in nude mice by targeting beta-catenin/TCF pathway

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Optimization of a synthetic beta-catenin-dependent promoter for tumor-specific cancer gene therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Targeting of autonomous parvoviruses to colon cancer by insertion of Tcf sites in the P4 promoter.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Administration of PUMA adenovirus increases the sensitivity of esophageal cancer cells to anticancer drugs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

Gene targeting approach to selectively kill colon cancer cells, with hyperactive K-Ras pathway

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021

The cadherin-catenin adhesion system in signaling and cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22416

7 January 2021